Healthcare Policy Assessment Paper

Healthcare Policy Assessment Paper

Healthcare Policy Assessment Paper

Describe The Healthcare Program or Policy Outcomes

This policy guideline seeks to ensure that COVID-19 patients who are in home care can safely end their isolation without the risk of reinfection of infecting others. It is based on the evidence that COVID-19 patients who have become immunocompromised may remain infectious even 20 days after symptom presentation and this require additional COVID-19 testing with an infectious disease control expert or specialist. Therefore, the policy guideline assists public health officials and healthcare providers in managing COVID-19 patients who are in any other isolation facility (e.g., hotel, at home or dormitory room). Healthcare Policy Assessment Paper

How was the success of the program or policy measured?

The success of this policy guideline is measured by a reduced number of COVID-19 transmission from recovered patients, so much so that there is no justification for quarantine or retesting. Whereas there are millions of COVID-19 infections globally, investigations have so far revealed a few cases of reinfection (Roy, 2020), available evidence also show that some recovered patients would have a degree of immunity for at least 90 days after initial diagnosis and confirmation of COVID-19. This policy guideline would be considered successfully implemented if the degree of immunity persists to a level that there is no reinfection. Healthcare Policy Assessment Paper

How many people were reached by the program or policy selected?

Currently, according to World Health Organization (2021), there are 199 million confirmed cases of COVID-19, with at least 4 million deaths. This policy guideline could be a potentially useful in the management of the 199 million confirmed cases, who might recover and get re-infected. As such, this policy guideline targets and may impact any COVID-19 patients who might recover and get re-infected. Healthcare Policy Assessment Paper

At what point in program implementation was the program or policy evaluation conducted

The effectiveness of this guideline can be evaluated after testing for discontinuation has been done. It is only after testing negative for COVID-19 that a reinfection or non-reinfection can be established. The exitance of reinfection indicates that the guideline was not effectively implemented while a non-existence of reinfection indicates that the guideline was successfully implemented.

What data was used to conduct the program or policy evaluation

As indicated above, results from the testing for discontinuing isolation or precaution can be used as data for evaluating the successful or unsuccessful implementation of the guideline. Healthcare Policy Assessment Paper

What specific information on unintended consequences was identified?

These guidelines might display different consequences between individuals infected with SAR-CoV-2 and those exposed to SAR-CoV-2. Therefore, as per the guidelines, a 14-day quarantine is recommended after exposure depending on the time taken to develop the illness upon infection. As such, it is possible that an infected individual can leave isolation earlier than an individual who is quarantined based on the suspicion that they are infected. Healthcare Policy Assessment Paper

What stakeholders were identified in the evaluation of the program or policy? Who would benefit most from the results and reporting of the program or policy evaluation?

The main stakeholders of focus in this guideline are COVID-19 patients under home-based isolation. Nonetheless, other stakeholders include public health officers and healthcare providers.

Did the program or policy meet the original intent and objectives? Why or why not?

The guideline has hardly met its originally intended objectives of reducing reinfections because existing research show patients experiencing reinfection with different strains, and in some cases, the reinfection may occur with more severe infections (Wang et al., 2021 Healthcare Policy Assessment Paper)

Would you recommend implementing this program or policy in your place of work? Why or why not?

Yes, I would recommend the use of this practice guideline in my place of work because it would play a critical role in avoiding the reinfection of immunocompromised COVID-19 patients several days after symptom onset. This would especially be useful for a safe discontinuation of isolation for patients not in the hospital setting, avoiding the risk of infecting several others whom they may be in contact with.

Identify at least two ways that you, as a nurse advocate, could become involved in evaluating a program or policy after 1 year of implementation.

There are various questions that nurses can as part of a program or policy evaluation procedure depending on the type of program, and how long it takes to full implementation. For instance, one can evaluate the program implementation by questioning whether its activities were executed as earlier intended. Also, one can evaluate the program’s effectiveness by questioning whether the program has achieved its earlier intended objectives and goals. More importantly, the program’s efficiency can be evaluated by questioning whether it used the appropriate resources including staff time and budget.

Healthcare Policy Assessment Paper References

Roy, S. (2020). COVID-19 reinfection: myth or truth?. SN Comprehensive Clinical Medicine,  2(6), 710-713. https://doi.org/10.1007/s42399-020-00335-8

World Health Organization. (2021). Coronavirus Dashboard. Overview. Retrieved 4th August 2021 from https://covid19.who.int/

Wang, J., Kaperak, C., Sato, T. & Sakuraba, A. (2021). COVID-19 reinfection: a rapid systematic review of case reports and case series. Journal of Investigative Medicine, 69:1253-1255. http://orcid.org/0000-0003-2519-6129

Healthcare Policy Assessment Paper Instructions

Using the Healthcare Program/Policy Evaluation Analysis template address the following: Describe the healthcare program or policy outcomes.

How was the success of the program or policy measured?

How many people were reached by the program or policy selected?

How much of an impact was realized with the program or policy selected?

At what point in program implementation was the program or policy evaluation conducted?

What data was used to conduct the program or policy evaluation?

What specific information on unintended consequences was identified?

What stakeholders were identified in the evaluation of the program or policy? Who would benefit most from the results and reporting of the program or policy evaluation? Be specific and provide examples.
Did the program or policy meet the original intent and objectives? Why or why not?

Would you recommend implementing this program or policy in your place of work? Why or why not?
Identify at least two ways that you, as a nurse advocate, could become involved in evaluating a program or policy after 1 year of implementation. The template and rubric are attached